Navigation Links
GDS International's Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
Date:7/26/2012

MILAN, July 26, 2012 /PRNewswire/ --

On the 5th to the 7th of November, a distinguished consortium of 50 C-level executives will head to the Meliá Milano Hotel, Milan, in Italy, for two days as they attend GDS International's highly anticipated fourth Next Generation Pharmaceutical Drug Development summit (NGP DD EU4).

The development of targeted therapies and the potential for personalised medicine appears to have generated a significant demand in offering an accurate and reliable means of identifying patients who will benefit from treatment in clinical practice. However, as a result, companies are increasingly being forced to consider options for establishing an accompanying patient-selection diagnostic framework at earlier stages in development.

With this in mind, the NGP DD EU4 summit will focus on a variety of common pain points that are present within the industry today. Combining high-level roundtable discussions with next generation technology solutions that have been specifically tailored to address key topics within the European pharmaceutical sector, workshops from the delegation - as well as from Waters Corporation and Selventa - will shed new light on these issues.

In attendance will be a selection of some of the industry's most prominent thought leaders who will be contributing to the direction of the summit through topic-specific panel discussions. Sibo de Jong, VP Pharmaceutical R&D for Astellas Pharma; Henning Steinhagen, VP Global Preclinical R&D for Gruenenthal; Andrew Parsons, VP Pre-Clinical Drug Development for GSK; Anders Ullman, R&D Transition Lead for Takeda Global Research & Development Center Inc.; and Conrad Bleul, Director Translational Medicine for Novartis are but a few of the senior members scheduled for attendance.

Dr Alexander Alanine, Head of Technologies and Innovation at F.Hoffmann-La Roche, was an attendee at last year's summit. He said: "The event provided a refreshingly exciting blend of science, technology, process and vendor solutions/discussions. Highly recommended, an excellent format and a valuable two-day deep dive into the full breadth of key issues in drug discovery and development."

Ruben Kempeneer, Summit Director for GDS International - the global events company behind NGP DD EU4 - agreed, stating: "Research and development need to collaborate more closely, and then drive greater collaboration with clinical partners in an R & D & C model. Collaborations across pharma, biotech, academia, and even regulators and payers will yield the best results. The NGP Drug Development Summit will continue to act as a unique opportunity for senior executives across the drug discovery and development continuum to learn, network and do business."

For more information, please visit http://www.pharmasummiteurope.com

About GDS International

GDS International is one of the most innovative events and media companies worldwide - and a globally renowned producer of business-to-business summits, conferences, online information and advisory group gatherings. Founded in 1993, GDS International specialises in meeting the B2B marketing needs of our clients. Having a strong presence in mature industrial sectors but a finger on the pulse of emerging markets - as well as up-and-coming B2B business verticals - means we are perfectly placed to capitalise on the exciting developments brought about by the advent of a globalised economy. Our value proposition is simple: we deliver tangible business results from world-class events.

http://www.gdsinternational.com

Contact: Kimberley Hogarth
kimberley.hogarth@gdsinternational.com
+44-1179-261-420



'/>"/>
SOURCE GDS International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
2. Cardica To Announce Fiscal 2012 Fourth Quarter And Full Year Financial Results On Thursday, August 2, 2012
3. FDAnews announces Fourth Annual Supplier Quality Congress
4. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
5. Fourth Annual Spine Technology Awards to Recognize Excellence and Innovation
6. Bacterin International Signs Its Fourth National GPO Contract with the Premier healthcare alliance
7. Cardinal Health To Release Fourth-Quarter And Full-Year Results For Fiscal Year 2012 On Aug. 2
8. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
9. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
10. Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter
11. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 Research and Markets has announced ... report to their offering. ... The global travel vaccines market to grow at a ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the sales of various vaccines ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Ophthalmic Lasers ... report, "Australia Ophthalmic Lasers Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segements - Excimer Lasers, Femtosecond Lasers and YAG Lasers. ... shares data for each of these market segements, and ...
(Date:12/8/2016)... KEY FINDINGS The global medical ... Various reasons for growth of the medical lifting sling ... chronic diseases, high recovery cost of injuries and government ... lifting sling refers to an assistive device that helps ... connect to the lift and hold the patient. It ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... 08, 2016 , ... STAT courier is pleased to announce that due to ... they are expanding their presence in Dallas. One of the most exciting parts for ... jobs to the Dallas and Forth Worth market. STAT takes pride in treating their ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the ... Series B led by Canvas Ventures . Other investors include Nokia Growth Partners ... mobile platform to serve more consumers who are managing chronic conditions or ...
Breaking Medicine News(10 mins):